Customer Spotlight: Accelerating Organoid Development
IPSCs and organoids offer a powerful platform for modeling disease & drug discovery. These models can deliver accurate insights which cannot be provided by immortalized cell lines or primary cells and are not subject to limitations of animal models. Notable disease models have been developed for cystic fibrosis, Alzheimer’s disease, and cancer. The focus of […]